Literature DB >> 31541217

Evolving role of anti-VEGF for diabetic macular oedema: from clinical trials to real life.

Tarun Sharma1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31541217      PMCID： PMC7055591          DOI： 10.1038/s41433-019-0590-0

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  3 in total

1.  Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort.

Authors:  Anne Gedebjerg; Thomas Peter Almdal; Klara Berencsi; Jørgen Rungby; Jens Steen Nielsen; Daniel R Witte; Søren Friborg; Ivan Brandslund; Allan Vaag; Henning Beck-Nielsen; Henrik Toft Sørensen; Reimar Wernich Thomsen
Journal:  J Diabetes Complications       Date:  2017-09-19       Impact factor: 2.852

2.  Diabetes and its drivers: the largest epidemic in human history?

Authors:  Paul Z Zimmet
Journal:  Clin Diabetes Endocrinol       Date:  2017-01-18

3.  Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies.

Authors:  Érika B Rangel; Cláudia O Rodrigues; João R de Sá
Journal:  J Diabetes Res       Date:  2019-02-17       Impact factor: 4.011
  3 in total
  4 in total

1.  Dysregulated Serum Lipid Metabolism Promotes the Occurrence and Development of Diabetic Retinopathy Associated With Upregulated Circulating Levels of VEGF-A, VEGF-D, and PlGF.

Authors:  Xinyuan Zhang; Bingjie Qiu; Qiyun Wang; Sobha Sivaprasad; Yanhong Wang; Lin Zhao; Rui Xie; Lei Li; Wenting Kang
Journal:  Front Med (Lausanne)       Date:  2021-11-22

2.  Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema.

Authors:  Yousra Gamal Zakaria; Abdelrahman Gaber Salman; Azza Mohamed Ahmed Said; Mona Kamal Abdelatif
Journal:  Clin Ophthalmol       Date:  2022-03-11

3.  The effect of vitamin D supplementation on the outcome of treatment with bevacizumab in diabetic macular edema: a randomized clinical trial.

Authors:  Sahba Fekri; Masoud Soheilian; Sepehr Roozdar; Seyed-Hossein Abtahi; Hosein Nouri
Journal:  Int Ophthalmol       Date:  2022-05-11       Impact factor: 2.029

4.  A Mechanistic Exploratory Study on the Therapeutic Efficacy of Astragaloside IV Against Diabetic Retinopathy Revealed by Network Pharmacology.

Authors:  Zhi-Hao Zhao; Min Xu; Cong Fu; Ying Huang; Ting-Hua Wang; Zhong-Fu Zuo; Xue-Zheng Liu
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.